Chinook Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare Conference
18 February 2021 - 8:15AM
Chinook Therapeutics, Inc. (NASDAQ: KDNY), a biopharmaceutical
company focused on the discovery, development and commercialization
of precision medicines for kidney diseases, today announced that
Chinook management is scheduled to participate in a virtual
fireside chat at the 10th Annual SVB Leerink Global Healthcare
Conference on Wednesday, February 24, 2021 at 10:00 am ET.
To access the live webcast and subsequent archived recording of
this and other company presentations, please visit the Investors
section of Chinook’s website. The archived webcast will remain
available for replay on Chinook’s website for 90 days.
About Chinook Therapeutics, Inc.Chinook
Therapeutics, Inc. is a clinical-stage biotechnology company
developing precision medicines for kidney diseases. Chinook’s
product candidates are being investigated in rare, severe chronic
kidney disorders with opportunities for well-defined clinical
pathways. Chinook’s lead program is atrasentan, an investigational
phase 3 endothelin receptor antagonist for the treatment of IgA
nephropathy and other primary glomerular diseases. BION-1301, an
investigational anti-APRIL monoclonal antibody is being evaluated
in a phase 1b trial for IgA nephropathy. In addition, Chinook is
advancing CHK-336, an investigational oral small molecule LDHA
inhibitor for the treatment of primary hyperoxaluria, as well as
research programs for other rare, severe chronic kidney diseases,
including polycystic kidney disease. Chinook is building its
pipeline by leveraging insights in kidney single cell RNA
sequencing, human-derived organoids and new translational models,
to discover and develop therapeutics with differentiating
mechanisms of action against key kidney disease pathways. To learn
more, visit www.chinooktx.com.
Contact:Noopur LiffickVice President, Investor
Relations & Corporate Communicationsinvestors@chinooktx.com
media@chinooktx.com
Chinook Therapeutics (NASDAQ:KDNY)
Historical Stock Chart
From Apr 2024 to May 2024
Chinook Therapeutics (NASDAQ:KDNY)
Historical Stock Chart
From May 2023 to May 2024